HEADER HYDROLASE 06-OCT-04 1XOQ TITLE CATALYTIC DOMAIN OF HUMAN PHOSPHODIESTERASE 4D IN COMPLEX WITH TITLE 2 ROFLUMILAST COMPND MOL_ID: 1; COMPND 2 MOLECULE: CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: CATALYTIC DOMAIN OF HUMAN PHOSPHODIESTERASE 4D; COMPND 5 SYNONYM: DPDE3, PDE43; COMPND 6 EC: 3.1.4.17; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: PDE4D; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3)CODON PLUS(RIL); SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET15B KEYWDS PHOSPHODIESTERASE, PDE, PDE4D, ROFLUMILAST, HYDROLASE EXPDTA X-RAY DIFFRACTION AUTHOR G.L.CARD,B.P.ENGLAND,Y.SUZUKI,D.FONG,B.POWELL,B.LEE,C.LUU, AUTHOR 2 M.TABRIZIZAD,S.GILLETTE,P.N.IBRAHIM,D.R.ARTIS,G.BOLLAG,M.V.MILBURN, AUTHOR 3 S.-H.KIM,J.SCHLESSINGER,K.Y.J.ZHANG REVDAT 3 13-JUL-11 1XOQ 1 VERSN REVDAT 2 24-FEB-09 1XOQ 1 VERSN REVDAT 1 14-DEC-04 1XOQ 0 JRNL AUTH G.L.CARD,B.P.ENGLAND,Y.SUZUKI,D.FONG,B.POWELL,B.LEE,C.LUU, JRNL AUTH 2 M.TABRIZIZAD,S.GILLETTE,P.N.IBRAHIM,D.R.ARTIS,G.BOLLAG, JRNL AUTH 3 M.V.MILBURN,S.-H.KIM,J.SCHLESSINGER,K.Y.J.ZHANG JRNL TITL STRUCTURAL BASIS FOR THE ACTIVITY OF DRUGS THAT INHIBIT JRNL TITL 2 PHOSPHODIESTERASES. JRNL REF STRUCTURE V. 12 2233 2004 JRNL REFN ISSN 0969-2126 JRNL PMID 15576036 JRNL DOI 10.1016/J.STR.2004.10.004 REMARK 2 REMARK 2 RESOLUTION. 1.83 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.1.25 REMARK 3 AUTHORS : MURSHUDOV,VAGIN,DODSON REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.83 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 81.65 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 96.8 REMARK 3 NUMBER OF REFLECTIONS : 64048 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.178 REMARK 3 R VALUE (WORKING SET) : 0.177 REMARK 3 FREE R VALUE : 0.205 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 3402 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.83 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.88 REMARK 3 REFLECTION IN BIN (WORKING SET) : 4235 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 BIN R VALUE (WORKING SET) : 0.2780 REMARK 3 BIN FREE R VALUE SET COUNT : 238 REMARK 3 BIN FREE R VALUE : 0.3070 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 5253 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 152 REMARK 3 SOLVENT ATOMS : 360 REMARK 3 REMARK 3 B VALUES. REMARK 3 B VALUE TYPE : LIKELY RESIDUAL REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 8.76 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.05000 REMARK 3 B22 (A**2) : 0.98000 REMARK 3 B33 (A**2) : -0.93000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.126 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.116 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.081 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 2.754 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.955 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.941 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 5573 ; 0.009 ; 0.021 REMARK 3 BOND LENGTHS OTHERS (A): 4898 ; 0.002 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 7536 ; 1.261 ; 1.956 REMARK 3 BOND ANGLES OTHERS (DEGREES): 11430 ; 0.960 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 665 ; 2.730 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): NULL ; NULL ; NULL REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 856 ; 0.097 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 6109 ; 0.007 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 1047 ; 0.006 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 1364 ; 0.207 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): 5664 ; 0.230 ; 0.200 REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): 2996 ; 0.083 ; 0.200 REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 320 ; 0.132 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 10 ; 0.151 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): 43 ; 0.332 ; 0.200 REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 18 ; 0.155 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 3302 ; 0.428 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 5391 ; 0.834 ; 2.000 REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 2271 ; 1.532 ; 3.000 REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 2139 ; 2.527 ; 4.500 REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 2 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 86 A 411 REMARK 3 ORIGIN FOR THE GROUP (A): 17.6624 18.3874 56.2690 REMARK 3 T TENSOR REMARK 3 T11: 0.0431 T22: 0.0611 REMARK 3 T33: 0.0679 T12: 0.0142 REMARK 3 T13: -0.0062 T23: -0.0032 REMARK 3 L TENSOR REMARK 3 L11: 1.0027 L22: 1.0829 REMARK 3 L33: 1.9750 L12: -0.1431 REMARK 3 L13: -0.0982 L23: -0.5273 REMARK 3 S TENSOR REMARK 3 S11: 0.0079 S12: 0.0267 S13: -0.0749 REMARK 3 S21: -0.0637 S22: -0.0554 S23: -0.0305 REMARK 3 S31: 0.0775 S32: 0.1057 S33: 0.0475 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 NUMBER OF COMPONENTS GROUP : 2 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : B 86 B 292 REMARK 3 RESIDUE RANGE : B 297 B 411 REMARK 3 ORIGIN FOR THE GROUP (A): 16.0448 30.0295 95.1425 REMARK 3 T TENSOR REMARK 3 T11: 0.0370 T22: 0.0088 REMARK 3 T33: 0.0518 T12: -0.0005 REMARK 3 T13: 0.0254 T23: 0.0170 REMARK 3 L TENSOR REMARK 3 L11: 1.3774 L22: 0.8558 REMARK 3 L33: 1.7794 L12: -0.1392 REMARK 3 L13: 0.4849 L23: -0.0838 REMARK 3 S TENSOR REMARK 3 S11: 0.0038 S12: -0.0026 S13: 0.0863 REMARK 3 S21: -0.0280 S22: 0.0057 S23: -0.0452 REMARK 3 S31: -0.0491 S32: -0.0170 S33: -0.0095 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : BABINET MODEL WITH MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 1XOQ COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 22-NOV-04. REMARK 100 THE RCSB ID CODE IS RCSB030588. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 31-MAR-04 REMARK 200 TEMPERATURE (KELVIN) : 93 REMARK 200 PH : 7.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ALS REMARK 200 BEAMLINE : 8.3.1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.1 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 210 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : BLU-ICE REMARK 200 DATA SCALING SOFTWARE : ELVES REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 64048 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.830 REMARK 200 RESOLUTION RANGE LOW (A) : 81.650 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 96.8 REMARK 200 DATA REDUNDANCY : 3.100 REMARK 200 R MERGE (I) : 0.05800 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 1.9000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.83 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.88 REMARK 200 COMPLETENESS FOR SHELL (%) : 90.4 REMARK 200 DATA REDUNDANCY IN SHELL : 2.40 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 0.508 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: EPMR REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 49.28 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.42 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG3350, ETHYLENE GLYCOL, ISOPROPANOL, REMARK 280 GLYCEROL AND DTT , PH 7.0, VAPOR DIFFUSION, SITTING DROP, REMARK 280 TEMPERATURE 288K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 39.44950 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 81.99800 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 30.05800 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 81.99800 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 39.44950 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 30.05800 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: THE BIOLOGICAL ASSEMBLY IS ONE MONOMER. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 65 REMARK 465 GLY A 66 REMARK 465 SER A 67 REMARK 465 SER A 68 REMARK 465 HIS A 69 REMARK 465 HIS A 70 REMARK 465 HIS A 71 REMARK 465 HIS A 72 REMARK 465 HIS A 73 REMARK 465 HIS A 74 REMARK 465 SER A 75 REMARK 465 SER A 76 REMARK 465 GLY A 77 REMARK 465 LEU A 78 REMARK 465 VAL A 79 REMARK 465 PRO A 80 REMARK 465 ARG A 81 REMARK 465 GLY A 82 REMARK 465 SER A 83 REMARK 465 HIS A 84 REMARK 465 MET A 85 REMARK 465 GLN A 412 REMARK 465 SER A 413 REMARK 465 MET B 65 REMARK 465 GLY B 66 REMARK 465 SER B 67 REMARK 465 SER B 68 REMARK 465 HIS B 69 REMARK 465 HIS B 70 REMARK 465 HIS B 71 REMARK 465 HIS B 72 REMARK 465 HIS B 73 REMARK 465 HIS B 74 REMARK 465 SER B 75 REMARK 465 SER B 76 REMARK 465 GLY B 77 REMARK 465 LEU B 78 REMARK 465 VAL B 79 REMARK 465 PRO B 80 REMARK 465 ARG B 81 REMARK 465 GLY B 82 REMARK 465 SER B 83 REMARK 465 HIS B 84 REMARK 465 MET B 85 REMARK 465 THR B 293 REMARK 465 SER B 294 REMARK 465 SER B 295 REMARK 465 GLY B 296 REMARK 465 GLN B 412 REMARK 465 SER B 413 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ASP B 151 CB - CG - OD2 ANGL. DEV. = 5.7 DEGREES REMARK 500 ASP B 156 CB - CG - OD2 ANGL. DEV. = 5.6 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ILE A 376 -60.70 -122.82 REMARK 500 ILE B 376 -57.66 -124.20 REMARK 500 REMARK 500 REMARK: NULL REMARK 600 REMARK 600 HETEROGEN REMARK 600 HOH 1003-1008 ARE ASSOCIATED WITH CHAIN A. REMARK 600 HOH 2003-2008 ARE ASSOCIATED WITH CHAIN B. REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN A1001 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ASP A 201 OD2 REMARK 620 2 HIS A 164 NE2 87.6 REMARK 620 3 HIS A 200 NE2 87.6 94.7 REMARK 620 4 ASP A 318 OD1 174.7 91.6 87.2 REMARK 620 5 HOH A1010 O 89.2 167.7 97.1 92.6 REMARK 620 6 HOH A1011 O 101.1 88.1 171.0 84.1 80.9 REMARK 620 N 1 2 3 4 5 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 MG A1002 MG REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ASP A 201 OD1 REMARK 620 2 HOH A1008 O 169.5 REMARK 620 3 HOH A1007 O 84.4 86.4 REMARK 620 4 HOH A1010 O 92.5 93.4 95.6 REMARK 620 5 HOH A1009 O 94.9 94.3 179.0 85.1 REMARK 620 6 HOH A1006 O 87.3 88.1 92.3 172.0 87.0 REMARK 620 N 1 2 3 4 5 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN B1001 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HOH B2007 O REMARK 620 2 ASP B 318 OD1 93.4 REMARK 620 3 ASP B 201 OD2 87.7 178.1 REMARK 620 4 HIS B 200 NE2 98.4 96.4 81.8 REMARK 620 5 HIS B 164 NE2 164.8 89.9 89.5 96.0 REMARK 620 6 HOH B2008 O 81.1 85.5 96.3 178.0 84.4 REMARK 620 N 1 2 3 4 5 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 MG B1002 MG REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HOH B2005 O REMARK 620 2 ASP B 201 OD1 168.4 REMARK 620 3 HOH B2006 O 91.0 97.9 REMARK 620 4 HOH B2004 O 85.5 85.2 175.3 REMARK 620 5 HOH B2007 O 95.9 92.6 83.4 100.1 REMARK 620 6 HOH B2003 O 87.1 85.9 86.8 89.9 169.8 REMARK 620 N 1 2 3 4 5 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ZN A 1001 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MG A 1002 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ZN B 1001 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MG B 1002 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO B 1003 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 1003 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO B 1004 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 1004 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC9 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO B 1005 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 1005 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 415 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 416 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO B 417 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO B 418 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 419 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 420 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 422 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC9 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO B 425 REMARK 800 REMARK 800 SITE_IDENTIFIER: CC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO B 427 REMARK 800 REMARK 800 SITE_IDENTIFIER: CC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO B 428 REMARK 800 REMARK 800 SITE_IDENTIFIER: CC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 429 REMARK 800 REMARK 800 SITE_IDENTIFIER: CC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO B 430 REMARK 800 REMARK 800 SITE_IDENTIFIER: CC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 433 REMARK 800 REMARK 800 SITE_IDENTIFIER: CC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO B 434 REMARK 800 REMARK 800 SITE_IDENTIFIER: CC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO B 441 REMARK 800 REMARK 800 SITE_IDENTIFIER: CC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 444 REMARK 800 REMARK 800 SITE_IDENTIFIER: CC9 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 445 REMARK 800 REMARK 800 SITE_IDENTIFIER: DC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO B 448 REMARK 800 REMARK 800 SITE_IDENTIFIER: DC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ROF A 502 REMARK 800 REMARK 800 SITE_IDENTIFIER: DC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ROF B 501 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1XLX RELATED DB: PDB REMARK 900 PDE4B IN COMPLEX WITH CILOMILAST REMARK 900 RELATED ID: 1XLZ RELATED DB: PDB REMARK 900 PDE4B IN COMPLEX WITH FILAMINAST REMARK 900 RELATED ID: 1XM4 RELATED DB: PDB REMARK 900 PDE4B IN COMPLEX WITH PICLAMILAST REMARK 900 RELATED ID: 1XM6 RELATED DB: PDB REMARK 900 PDE4B IN COMPLEX WITH (R)-MESOPRAM REMARK 900 RELATED ID: 1XMU RELATED DB: PDB REMARK 900 PDE4B IN COMPLEX WITH ROFLUMILAST REMARK 900 RELATED ID: 1XMY RELATED DB: PDB REMARK 900 PDE4B IN COMPLEX WITH (R)-ROLIPRAM REMARK 900 RELATED ID: 1XN0 RELATED DB: PDB REMARK 900 PDE4B IN COMPLEX WITH (R,S)-ROLIPRAM REMARK 900 RELATED ID: 1XOM RELATED DB: PDB REMARK 900 PDE4B IN COMPLEX WITH CILOMILAST REMARK 900 RELATED ID: 1XON RELATED DB: PDB REMARK 900 PDE4B IN COMPLEX WITH PICLAMILAST REMARK 900 RELATED ID: 1XOR RELATED DB: PDB REMARK 900 PDE4D IN COMPLEX WITH ZARDAVERINE REMARK 900 RELATED ID: 1XOS RELATED DB: PDB REMARK 900 PDE4B IN COMPLEX WITH SILDENAFIL REMARK 900 RELATED ID: 1XOT RELATED DB: PDB REMARK 900 PDE4B IN COMPLEX WITH VARDENAFIL REMARK 900 RELATED ID: 1XOZ RELATED DB: PDB REMARK 900 PDE5A IN COMPLEX WITH TADALAFIL REMARK 900 RELATED ID: 1XP0 RELATED DB: PDB REMARK 900 PDE5A IN COMPLEX WITH VARDENAFIL DBREF 1XOQ A 86 413 UNP Q08499 PDE4D_HUMAN 388 715 DBREF 1XOQ B 86 413 UNP Q08499 PDE4D_HUMAN 388 715 SEQADV 1XOQ MET A 65 UNP Q08499 INITIATING METHIONINE SEQADV 1XOQ GLY A 66 UNP Q08499 CLONING ARTIFACT SEQADV 1XOQ SER A 67 UNP Q08499 CLONING ARTIFACT SEQADV 1XOQ SER A 68 UNP Q08499 CLONING ARTIFACT SEQADV 1XOQ HIS A 69 UNP Q08499 EXPRESSION TAG SEQADV 1XOQ HIS A 70 UNP Q08499 EXPRESSION TAG SEQADV 1XOQ HIS A 71 UNP Q08499 EXPRESSION TAG SEQADV 1XOQ HIS A 72 UNP Q08499 EXPRESSION TAG SEQADV 1XOQ HIS A 73 UNP Q08499 EXPRESSION TAG SEQADV 1XOQ HIS A 74 UNP Q08499 EXPRESSION TAG SEQADV 1XOQ SER A 75 UNP Q08499 CLONING ARTIFACT SEQADV 1XOQ SER A 76 UNP Q08499 CLONING ARTIFACT SEQADV 1XOQ GLY A 77 UNP Q08499 CLONING ARTIFACT SEQADV 1XOQ LEU A 78 UNP Q08499 CLONING ARTIFACT SEQADV 1XOQ VAL A 79 UNP Q08499 CLONING ARTIFACT SEQADV 1XOQ PRO A 80 UNP Q08499 CLONING ARTIFACT SEQADV 1XOQ ARG A 81 UNP Q08499 CLONING ARTIFACT SEQADV 1XOQ GLY A 82 UNP Q08499 CLONING ARTIFACT SEQADV 1XOQ SER A 83 UNP Q08499 CLONING ARTIFACT SEQADV 1XOQ HIS A 84 UNP Q08499 CLONING ARTIFACT SEQADV 1XOQ MET A 85 UNP Q08499 CLONING ARTIFACT SEQADV 1XOQ MET B 65 UNP Q08499 INITIATING METHIONINE SEQADV 1XOQ GLY B 66 UNP Q08499 CLONING ARTIFACT SEQADV 1XOQ SER B 67 UNP Q08499 CLONING ARTIFACT SEQADV 1XOQ SER B 68 UNP Q08499 CLONING ARTIFACT SEQADV 1XOQ HIS B 69 UNP Q08499 EXPRESSION TAG SEQADV 1XOQ HIS B 70 UNP Q08499 EXPRESSION TAG SEQADV 1XOQ HIS B 71 UNP Q08499 EXPRESSION TAG SEQADV 1XOQ HIS B 72 UNP Q08499 EXPRESSION TAG SEQADV 1XOQ HIS B 73 UNP Q08499 EXPRESSION TAG SEQADV 1XOQ HIS B 74 UNP Q08499 EXPRESSION TAG SEQADV 1XOQ SER B 75 UNP Q08499 CLONING ARTIFACT SEQADV 1XOQ SER B 76 UNP Q08499 CLONING ARTIFACT SEQADV 1XOQ GLY B 77 UNP Q08499 CLONING ARTIFACT SEQADV 1XOQ LEU B 78 UNP Q08499 CLONING ARTIFACT SEQADV 1XOQ VAL B 79 UNP Q08499 CLONING ARTIFACT SEQADV 1XOQ PRO B 80 UNP Q08499 CLONING ARTIFACT SEQADV 1XOQ ARG B 81 UNP Q08499 CLONING ARTIFACT SEQADV 1XOQ GLY B 82 UNP Q08499 CLONING ARTIFACT SEQADV 1XOQ SER B 83 UNP Q08499 CLONING ARTIFACT SEQADV 1XOQ HIS B 84 UNP Q08499 CLONING ARTIFACT SEQADV 1XOQ MET B 85 UNP Q08499 CLONING ARTIFACT SEQRES 1 A 349 MET GLY SER SER HIS HIS HIS HIS HIS HIS SER SER GLY SEQRES 2 A 349 LEU VAL PRO ARG GLY SER HIS MET THR GLU GLN GLU ASP SEQRES 3 A 349 VAL LEU ALA LYS GLU LEU GLU ASP VAL ASN LYS TRP GLY SEQRES 4 A 349 LEU HIS VAL PHE ARG ILE ALA GLU LEU SER GLY ASN ARG SEQRES 5 A 349 PRO LEU THR VAL ILE MET HIS THR ILE PHE GLN GLU ARG SEQRES 6 A 349 ASP LEU LEU LYS THR PHE LYS ILE PRO VAL ASP THR LEU SEQRES 7 A 349 ILE THR TYR LEU MET THR LEU GLU ASP HIS TYR HIS ALA SEQRES 8 A 349 ASP VAL ALA TYR HIS ASN ASN ILE HIS ALA ALA ASP VAL SEQRES 9 A 349 VAL GLN SER THR HIS VAL LEU LEU SER THR PRO ALA LEU SEQRES 10 A 349 GLU ALA VAL PHE THR ASP LEU GLU ILE LEU ALA ALA ILE SEQRES 11 A 349 PHE ALA SER ALA ILE HIS ASP VAL ASP HIS PRO GLY VAL SEQRES 12 A 349 SER ASN GLN PHE LEU ILE ASN THR ASN SER GLU LEU ALA SEQRES 13 A 349 LEU MET TYR ASN ASP SER SER VAL LEU GLU ASN HIS HIS SEQRES 14 A 349 LEU ALA VAL GLY PHE LYS LEU LEU GLN GLU GLU ASN CYS SEQRES 15 A 349 ASP ILE PHE GLN ASN LEU THR LYS LYS GLN ARG GLN SER SEQRES 16 A 349 LEU ARG LYS MET VAL ILE ASP ILE VAL LEU ALA THR ASP SEQRES 17 A 349 MET SER LYS HIS MET ASN LEU LEU ALA ASP LEU LYS THR SEQRES 18 A 349 MET VAL GLU THR LYS LYS VAL THR SER SER GLY VAL LEU SEQRES 19 A 349 LEU LEU ASP ASN TYR SER ASP ARG ILE GLN VAL LEU GLN SEQRES 20 A 349 ASN MET VAL HIS CYS ALA ASP LEU SER ASN PRO THR LYS SEQRES 21 A 349 PRO LEU GLN LEU TYR ARG GLN TRP THR ASP ARG ILE MET SEQRES 22 A 349 GLU GLU PHE PHE ARG GLN GLY ASP ARG GLU ARG GLU ARG SEQRES 23 A 349 GLY MET GLU ILE SER PRO MET CYS ASP LYS HIS ASN ALA SEQRES 24 A 349 SER VAL GLU LYS SER GLN VAL GLY PHE ILE ASP TYR ILE SEQRES 25 A 349 VAL HIS PRO LEU TRP GLU THR TRP ALA ASP LEU VAL HIS SEQRES 26 A 349 PRO ASP ALA GLN ASP ILE LEU ASP THR LEU GLU ASP ASN SEQRES 27 A 349 ARG GLU TRP TYR GLN SER THR ILE PRO GLN SER SEQRES 1 B 349 MET GLY SER SER HIS HIS HIS HIS HIS HIS SER SER GLY SEQRES 2 B 349 LEU VAL PRO ARG GLY SER HIS MET THR GLU GLN GLU ASP SEQRES 3 B 349 VAL LEU ALA LYS GLU LEU GLU ASP VAL ASN LYS TRP GLY SEQRES 4 B 349 LEU HIS VAL PHE ARG ILE ALA GLU LEU SER GLY ASN ARG SEQRES 5 B 349 PRO LEU THR VAL ILE MET HIS THR ILE PHE GLN GLU ARG SEQRES 6 B 349 ASP LEU LEU LYS THR PHE LYS ILE PRO VAL ASP THR LEU SEQRES 7 B 349 ILE THR TYR LEU MET THR LEU GLU ASP HIS TYR HIS ALA SEQRES 8 B 349 ASP VAL ALA TYR HIS ASN ASN ILE HIS ALA ALA ASP VAL SEQRES 9 B 349 VAL GLN SER THR HIS VAL LEU LEU SER THR PRO ALA LEU SEQRES 10 B 349 GLU ALA VAL PHE THR ASP LEU GLU ILE LEU ALA ALA ILE SEQRES 11 B 349 PHE ALA SER ALA ILE HIS ASP VAL ASP HIS PRO GLY VAL SEQRES 12 B 349 SER ASN GLN PHE LEU ILE ASN THR ASN SER GLU LEU ALA SEQRES 13 B 349 LEU MET TYR ASN ASP SER SER VAL LEU GLU ASN HIS HIS SEQRES 14 B 349 LEU ALA VAL GLY PHE LYS LEU LEU GLN GLU GLU ASN CYS SEQRES 15 B 349 ASP ILE PHE GLN ASN LEU THR LYS LYS GLN ARG GLN SER SEQRES 16 B 349 LEU ARG LYS MET VAL ILE ASP ILE VAL LEU ALA THR ASP SEQRES 17 B 349 MET SER LYS HIS MET ASN LEU LEU ALA ASP LEU LYS THR SEQRES 18 B 349 MET VAL GLU THR LYS LYS VAL THR SER SER GLY VAL LEU SEQRES 19 B 349 LEU LEU ASP ASN TYR SER ASP ARG ILE GLN VAL LEU GLN SEQRES 20 B 349 ASN MET VAL HIS CYS ALA ASP LEU SER ASN PRO THR LYS SEQRES 21 B 349 PRO LEU GLN LEU TYR ARG GLN TRP THR ASP ARG ILE MET SEQRES 22 B 349 GLU GLU PHE PHE ARG GLN GLY ASP ARG GLU ARG GLU ARG SEQRES 23 B 349 GLY MET GLU ILE SER PRO MET CYS ASP LYS HIS ASN ALA SEQRES 24 B 349 SER VAL GLU LYS SER GLN VAL GLY PHE ILE ASP TYR ILE SEQRES 25 B 349 VAL HIS PRO LEU TRP GLU THR TRP ALA ASP LEU VAL HIS SEQRES 26 B 349 PRO ASP ALA GLN ASP ILE LEU ASP THR LEU GLU ASP ASN SEQRES 27 B 349 ARG GLU TRP TYR GLN SER THR ILE PRO GLN SER HET ZN A1001 1 HET MG A1002 1 HET ZN B1001 1 HET MG B1002 1 HET EDO B1003 4 HET EDO A1003 4 HET EDO B1004 4 HET EDO A1004 4 HET EDO B1005 4 HET EDO A1005 4 HET EDO A 415 4 HET EDO A 416 4 HET EDO B 417 4 HET EDO B 418 4 HET EDO A 419 4 HET EDO A 420 4 HET EDO A 422 4 HET EDO B 425 4 HET EDO B 427 4 HET EDO B 428 4 HET EDO A 429 4 HET EDO B 430 4 HET EDO A 433 4 HET EDO B 434 4 HET EDO B 441 4 HET EDO A 444 4 HET EDO A 445 4 HET EDO B 448 4 HET ROF A 502 26 HET ROF B 501 26 HETNAM ZN ZINC ION HETNAM MG MAGNESIUM ION HETNAM EDO 1,2-ETHANEDIOL HETNAM ROF 3-(CYCLOPROPYLMETHOXY)-N-(3,5-DICHLOROPYRIDIN-4-YL)-4- HETNAM 2 ROF (DIFLUOROMETHOXY)BENZAMIDE HETSYN EDO ETHYLENE GLYCOL HETSYN ROF ROFLUMILAST FORMUL 3 ZN 2(ZN 2+) FORMUL 4 MG 2(MG 2+) FORMUL 7 EDO 24(C2 H6 O2) FORMUL 31 ROF 2(C17 H14 CL2 F2 N2 O3) FORMUL 33 HOH *360(H2 O) HELIX 1 1 THR A 86 GLU A 97 1 12 HELIX 2 2 HIS A 105 SER A 113 1 9 HELIX 3 3 ARG A 116 ARG A 129 1 14 HELIX 4 4 ASP A 130 PHE A 135 1 6 HELIX 5 5 PRO A 138 HIS A 152 1 15 HELIX 6 6 ASN A 161 SER A 177 1 17 HELIX 7 7 THR A 178 GLU A 182 5 5 HELIX 8 8 THR A 186 HIS A 200 1 15 HELIX 9 9 SER A 208 THR A 215 1 8 HELIX 10 10 SER A 217 ASN A 224 1 8 HELIX 11 11 SER A 227 LEU A 240 1 14 HELIX 12 12 LEU A 241 GLU A 243 5 3 HELIX 13 13 THR A 253 ALA A 270 1 18 HELIX 14 14 THR A 271 SER A 274 5 4 HELIX 15 15 LYS A 275 THR A 289 1 15 HELIX 16 16 ASN A 302 LEU A 319 1 18 HELIX 17 17 SER A 320 LYS A 324 5 5 HELIX 18 18 PRO A 325 ARG A 350 1 26 HELIX 19 19 SER A 364 ILE A 376 1 13 HELIX 20 20 ILE A 376 VAL A 388 1 13 HELIX 21 21 ALA A 392 THR A 409 1 18 HELIX 22 22 THR B 86 GLU B 97 1 12 HELIX 23 23 HIS B 105 SER B 113 1 9 HELIX 24 24 ARG B 116 ARG B 129 1 14 HELIX 25 25 ASP B 130 PHE B 135 1 6 HELIX 26 26 PRO B 138 HIS B 152 1 15 HELIX 27 27 ASN B 161 SER B 177 1 17 HELIX 28 28 THR B 178 GLU B 182 5 5 HELIX 29 29 THR B 186 HIS B 200 1 15 HELIX 30 30 SER B 208 THR B 215 1 8 HELIX 31 31 SER B 217 ASN B 224 1 8 HELIX 32 32 SER B 227 LEU B 240 1 14 HELIX 33 33 LEU B 241 GLU B 243 5 3 HELIX 34 34 THR B 253 ALA B 270 1 18 HELIX 35 35 THR B 271 SER B 274 5 4 HELIX 36 36 LYS B 275 THR B 289 1 15 HELIX 37 37 ASN B 302 LEU B 319 1 18 HELIX 38 38 SER B 320 LYS B 324 5 5 HELIX 39 39 PRO B 325 ARG B 350 1 26 HELIX 40 40 SER B 364 ILE B 376 1 13 HELIX 41 41 ILE B 376 VAL B 388 1 13 HELIX 42 42 ALA B 392 ILE B 410 1 19 LINK ZN ZN A1001 OD2 ASP A 201 1555 1555 2.12 LINK ZN ZN A1001 NE2 HIS A 164 1555 1555 2.17 LINK ZN ZN A1001 NE2 HIS A 200 1555 1555 2.20 LINK ZN ZN A1001 OD1 ASP A 318 1555 1555 2.23 LINK ZN ZN A1001 O HOH A1010 1555 1555 2.18 LINK ZN ZN A1001 O HOH A1011 1555 1555 2.27 LINK MG MG A1002 OD1 ASP A 201 1555 1555 2.15 LINK MG MG A1002 O HOH A1008 1555 1555 2.12 LINK MG MG A1002 O HOH A1007 1555 1555 2.13 LINK MG MG A1002 O HOH A1010 1555 1555 2.07 LINK MG MG A1002 O HOH A1009 1555 1555 2.15 LINK MG MG A1002 O HOH A1006 1555 1555 2.14 LINK ZN ZN B1001 O HOH B2007 1555 1555 2.07 LINK ZN ZN B1001 OD1 ASP B 318 1555 1555 2.14 LINK ZN ZN B1001 OD2 ASP B 201 1555 1555 2.15 LINK ZN ZN B1001 NE2 HIS B 200 1555 1555 2.20 LINK ZN ZN B1001 NE2 HIS B 164 1555 1555 2.17 LINK ZN ZN B1001 O HOH B2008 1555 1555 2.28 LINK MG MG B1002 O HOH B2005 1555 1555 2.21 LINK MG MG B1002 OD1 ASP B 201 1555 1555 2.11 LINK MG MG B1002 O HOH B2006 1555 1555 2.15 LINK MG MG B1002 O HOH B2004 1555 1555 2.14 LINK MG MG B1002 O HOH B2007 1555 1555 2.09 LINK MG MG B1002 O HOH B2003 1555 1555 2.19 CISPEP 1 HIS A 389 PRO A 390 0 -0.73 CISPEP 2 HIS B 389 PRO B 390 0 0.96 SITE 1 AC1 6 HIS A 164 HIS A 200 ASP A 201 ASP A 318 SITE 2 AC1 6 HOH A1010 HOH A1011 SITE 1 AC2 6 ASP A 201 HOH A1006 HOH A1007 HOH A1008 SITE 2 AC2 6 HOH A1009 HOH A1010 SITE 1 AC3 6 HIS B 164 HIS B 200 ASP B 201 ASP B 318 SITE 2 AC3 6 HOH B2007 HOH B2008 SITE 1 AC4 6 ASP B 201 HOH B2003 HOH B2004 HOH B2005 SITE 2 AC4 6 HOH B2006 HOH B2007 SITE 1 AC5 4 PRO A 411 GLU B 366 TYR B 406 HOH B2051 SITE 1 AC6 5 LYS A 262 ILE A 265 ASP A 266 HOH A1038 SITE 2 AC6 5 ASN B 224 SITE 1 AC7 3 TRP A 405 HOH A1085 HOH B2100 SITE 1 AC8 8 ASN A 115 GLU A 150 ASP A 151 TYR A 153 SITE 2 AC8 8 ASN A 162 HOH A1093 HOH A1123 GLN B 407 SITE 1 AC9 3 SER B 208 PRO B 356 HOH B2015 SITE 1 BC1 6 PRO A 179 SER A 295 GLY A 296 HIS A 389 SITE 2 BC1 6 PRO A 390 ASP A 391 SITE 1 BC2 6 ASN A 115 ALA A 155 ASN A 161 ASN A 162 SITE 2 BC2 6 ILE A 163 HOH A1123 SITE 1 BC3 7 LEU A 175 THR A 178 TRP A 384 VAL A 388 SITE 2 BC3 7 ASP A 391 ALA A 392 HOH A1148 SITE 1 BC4 5 PHE B 238 PHE B 249 ARG B 257 EDO B 418 SITE 2 BC4 5 HOH B2097 SITE 1 BC5 5 ARG B 257 GLN B 258 ARG B 261 EDO B 417 SITE 2 BC5 5 HOH B2163 SITE 1 BC6 5 ALA A 183 VAL A 184 HOH A1071 ASN B 115 SITE 2 BC6 5 ARG B 116 SITE 1 BC7 5 PHE A 238 PHE A 249 ARG A 257 ARG A 261 SITE 2 BC7 5 HOH A1172 SITE 1 BC8 5 SER A 208 PHE A 340 PRO A 356 HOH A1043 SITE 2 BC8 5 HOH A1181 SITE 1 BC9 5 ASN A 224 LYS B 262 ILE B 265 ASP B 266 SITE 2 BC9 5 HOH B2029 SITE 1 CC1 3 ASN B 402 EDO B 428 HOH B2044 SITE 1 CC2 2 GLU A 366 EDO B 427 SITE 1 CC3 5 ASP A 151 HIS A 152 ASP B 374 TYR B 375 SITE 2 CC3 5 HOH B2105 SITE 1 CC4 8 ASP B 156 VAL B 157 ALA B 158 GLU B 339 SITE 2 CC4 8 ARG B 342 HOH B2037 HOH B2058 HOH B2120 SITE 1 CC5 3 HIS A 154 ASP A 203 PRO A 205 SITE 1 CC6 5 ASN B 115 ALA B 155 ASN B 162 HOH B2055 SITE 2 CC6 5 HOH B2181 SITE 1 CC7 3 MET B 273 MET B 277 HOH B2063 SITE 1 CC8 1 HOH A1048 SITE 1 CC9 6 ASP A 156 VAL A 157 ALA A 158 GLU A 339 SITE 2 CC9 6 ARG A 342 HOH A1042 SITE 1 DC1 4 SER B 368 PHE B 372 ILE B 376 ROF B 501 SITE 1 DC2 17 HIS A 160 THR A 271 MET A 273 ASP A 318 SITE 2 DC2 17 LEU A 319 ASN A 321 PRO A 322 TYR A 329 SITE 3 DC2 17 TRP A 332 THR A 333 ILE A 336 MET A 357 SITE 4 DC2 17 SER A 368 GLN A 369 PHE A 372 HOH A1008 SITE 5 DC2 17 HOH A1015 SITE 1 DC3 18 HIS B 160 THR B 271 MET B 273 ASP B 318 SITE 2 DC3 18 LEU B 319 ASN B 321 PRO B 322 TYR B 329 SITE 3 DC3 18 TRP B 332 THR B 333 ILE B 336 MET B 357 SITE 4 DC3 18 GLN B 369 PHE B 372 EDO B 448 HOH B2005 SITE 5 DC3 18 HOH B2009 HOH B2101 CRYST1 78.899 60.116 163.996 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.012674 0.000000 0.000000 0.00000 SCALE2 0.000000 0.016635 0.000000 0.00000 SCALE3 0.000000 0.000000 0.006098 0.00000 MASTER 574 0 30 42 0 0 57 6 0 0 0 54 END